Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
27 January 2022 - 11:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2022
Commission File Number: 001-39633
Abcam plc
(Translation of registrants name into English)
Discovery Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
(Address
of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On January 27, 2022, Abcam plc (the Company) issued a regulatory news service announcement (the Announcement) announcing
unaudited trading update ahead of its results for the twelve months ended December 31, 2020. The Announcement is furnished herewith as Exhibit 99.1 to this Report on Form 6-K.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
ABCAM PLC
|
|
|
|
|
|
|
Date: January 27, 2022
|
|
|
|
By:
|
|
/s/ Alan Hirzel
|
|
|
|
|
|
|
Name: Alan Hirzel
|
|
|
|
|
|
|
Title: Chief Executive Officer
|
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Feb 2024 to Mar 2024
Abcam (NASDAQ:ABCM)
Historical Stock Chart
From Mar 2023 to Mar 2024